AI assistant
Sending…
IDEAYA Biosciences, Inc. — Director's Dealing 2023
Feb 28, 2023
31547_dirs_2023-02-28_8b516427-7e48-43b4-9b4f-2aa6fd815fe8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEAYA Biosciences, Inc. (IDYA)
CIK: 0001676725
Period of Report: 2023-02-24
Reporting Person: Stone Paul A. (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-24 | Stock Option (right to buy) | $17.04 | A | 140000 | Acquired | 2033-02-23 | Common Stock (140000) | Direct |
Footnotes
F1: 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
More from IDEAYA Biosciences, Inc.
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Annual Report
2026
Feb 17
Major Shareholding Notification
2026
Feb 12